Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Total 13F shares
-
56,853,940
-
Share change
-
-3,121,579
-
Total reported value
-
$139,289,225
-
Put/Call ratio
-
80%
-
Price per share
-
$2.45
-
Number of holders
-
102
-
Value change
-
-$10,696,353
-
Number of buys
-
56
-
Number of sells
-
75
Institutional Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q2 2023
As of 30 Jun 2023 Kezar Life Sciences Inc - COMMON-STOCK (KZR) had 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 56,853,940 shares of stock of the company.
Largest 10 holders included SUVRETTA CAPITAL MANAGEMENT, LLC, Avidity Partners Management LP, ORBIMED ADVISORS LLC, BlackRock Inc., Prosight Management, LP, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, SPHERA FUNDS MANAGEMENT LTD., Granahan Investment Management, LLC, and FRANKLIN RESOURCES INC.
This table shows 102 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.